Skip to main content
. 2011 Dec 19;120(3):552–559. doi: 10.1182/blood-2011-06-360552

Table 1.

Patient disposition (ITT population: total N = 35)

No. (%)
Received study drug 34 (97.1)
Completed initial treatment phase 25 (71.4)
Received re-treatment 8 (22.9)
Completed follow-up period 16 (45.7)
Completed treatment 6 (17)
Reasons for discontinuation
    AE 1 (2.9)
    Disease progression 20 (57.1)
    DLT 2 (5.7)
    Investigator's decision 2 (5.7)
    Patient's decision 2 (5.7)
    Other 2 (5.7)

ITT indicates intent to treat.